Skip to content
Late-StageResearch compound

Proviron (Mesterolone)

An oral androgen hormone, a medicine in Germany, Austria and Poland and a banned doping substance in sport.

Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Proviron (Mesterolone) vial

DETAILED OVERVIEW

What is Proviron (Mesterolone)?

Proviron (active ingredient mesterolone) is an androgen taken by mouth, a male sex hormone similar to testosterone. In Germany, Austria and Poland it is a prescription medicine for reduced male fertility, delayed puberty and testosterone deficiency. It is not registered in Hungary.

It has only a weak muscle-building effect, so on its own it is not a mass-building drug. In bodybuilding it is used alongside testosterone: it binds the protein that carries sex hormones, so more testosterone is left free in the blood, and it slightly blocks estrogen formation as well. It is less of a burden on the liver than most steroids taken by mouth, but it can cause acne, body hair growth and faster hair loss, lowers HDL cholesterol (the beneficial kind) and stimulates the prostate. In women the risk of masculinization is considerable and partly irreversible. It must not be used in pregnancy or breastfeeding, because it can masculinize a female baby. It is banned in competitive sport all year round.

Mechanism

Weak androgen; more free testosterone; mild estrogen blocking

Anabolic:Androgenic

100:30-40

Half-life

12-13 hours

Onset

1-2 h (oral)

Legal status

Bayer Rx (DE/AT/PL), WADA-banned

Data console

Lab data

Androgenic:Anabolic100:30-40
AR bindingAR affinity weak (~10% vs testosterone). HIGH SHBG…
Active half-life12-13 h
Detection windowMesterolone metabolites (1α-methyl-5α-androstan-3-one metabolite family) urinary 4-5 weeks (Schänzer 1996 GC-MS methods). WADA-accredited.
AromatizationNo – 1α-methyl-DHT structure, NOT a CYP19 substrate; clinically also shows mild AI activity via its high SHBG affinity (Nieschlag-Behre 2012 testosterone monograph, Pope-Kanayama 2014 PMID 24423981)
HepatotoxicityLow – 1α-methyl group (NOT 17α!) provides weak hepatic first-pass stress; clinical ALT/AST rise rarely documented, much milder than Anavar or Dianabol. Long-term use (Bayer SmPC chronic Rx indication) hepatic profile relatively safe (Hartgens-Kuipers 2004 PMID 15233599)

Safety

Side effects, stop signs, contraindications

Side effects · 8

  • Androgenic effects: acne, oily skin, increased body hair; as mesterolone is a DHT-structural analog, the androgenic load is strong.
  • Acceleration of androgenetic hair loss in genetically predisposed users; finasteride does NOT protect, because mesterolone is an already-reduced DHT analog (not a 5α-reductase substrate).
  • Virilization in women: voice deepening, hirsutism, clitoral enlargement, menstrual disturbance; due to the low-anabolic/high-androgenic ratio the virilization risk is significant even at low doses and partly irreversible.
  • Adverse lipid profile: drop in HDL cholesterol (typically ~10-15%), which as an oral androgen raises atherosclerosis risk with prolonged use.
  • Prostate stimulation: the DHT analog directly drives prostate tissue, which can worsen benign prostatic hyperplasia symptoms (urinary difficulty) and raise PSA, especially over age 40.
  • HPTA suppression: on its own a mild-to-moderate suppression of native testosterone and spermatogenesis; at supraphysiological doses or as part of an AAS stack the HPTA suppression is pronounced.
  • Prolonged, painful erection (priapism) can occur as a sign of androgenic overstimulation; it requires urgent medical care.
  • Anticoagulant interaction: it can potentiate the blood-thinning effect of warfarin, leading to increased bleeding risk (INR monitoring required).

Contraindications · 7

  • Prostate carcinoma or known/suspected breast carcinoma in men: androgen-dependent tumors, mesterolone is absolutely contraindicated (Bayer SmPC).
  • Pregnancy and breastfeeding: the androgenic action can virilize the fetus (notably masculinization of a female fetus's external genitalia); absolute contraindication.
  • Women using it for aesthetic/performance goals: the low-anabolic/high-androgenic ratio makes the virilization risk disproportionate to the benefit, and partly irreversible.
  • Symptomatic benign prostatic hyperplasia (urinary obstruction): the DHT-analog androgen further stimulates the prostate and can worsen symptoms.
  • Personal/family history of androgenetic alopecia: mesterolone directly accelerates hair loss and finasteride offers no protection.
  • Pre-existing adverse lipids / cardiovascular risk (dyslipidemia, coronary disease): the HDL drop further worsens the risk, warranting caution/contraindication.
  • Severe hepatic or renal impairment: although mesterolone is not 17α-alkylated and has low hepatotoxicity, it should be avoided with existing organ failure due to altered hormone metabolism and fluid retention.

Related Performance Compounds

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Proviron (Mesterolone)?

Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.